Market Share of Human Recombinant Insulin Industry
The human recombinant insulin market studied is consolidated, as there are few companies that are dominating the market currently. Some of the key players that have a considerable share of this market include Eli Lilly and Company, Novo Nordisk, and Sanofi S.A., among others.
Human Recombinant Insulin Market Leaders
Novo Nordisk A/S
Eli Lilly and Company
Sanofi S.A.
Biocon
Zhuhai United Laboratories Co., Ltd.
*Disclaimer: Major Players sorted in no particular order
